middle.news
Starpharma Advances DEP® Pipeline and Expands Market Reach with $17.2M Cash Reserve
5:02am on Monday 2nd of June, 2025 AEST
•
Biotechnology
Read Story
Starpharma Advances DEP® Pipeline and Expands Market Reach with $17.2M Cash Reserve
5:02am on Monday 2nd of June, 2025 AEST
Key Points
DEP® SN38 clinical program delayed to FY26 for optimization
Partnership with Medicxi’s Petalion Therapeutics marks one year with strong collaboration
Launch of Star Navigator program to broaden dendrimer technology access
New marketing campaigns for Viraleze™ in UK and VivaGel® BV launches in Saudi Arabia and UAE
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
SPL
OPEN ARTICLE